The Journal of Urology® Home Study Course 2010 Volume 183/184

AUA CME Requirements

Accreditation: The American Urological Association (AUA) is accredited bythe Accreditation Council for Continuing Medical Education (ACCME) toprovide continuing medical education for physicians.

The AUA takes responsibility for the content, quality, and scientific integrityof this CME activity.

Credit Designation: The American Urological Association designates thiseducational activity for a maximum of 24.0 AMA PRA Category 1 Credits™.Physicians should only claim credit commensurate with the extent of theirparticipation in the activity.

Target Audience: The Journal of Urology® Home Study Course is de-signed for practicing urologic physicians, American Board of Urology (ABU)candidates and/or residents.

Program Description and Objectives: The Journal of Urology® Home StudyCourse is a comprehensive learning activity developed by a team of educa-tors, academicians and clinicians. After completing each lesson, the partici-pants should be able to assess their knowledge of urology, demonstrate anincreased knowledge base of urology, and apply the increased knowledge toimprove quality of patient care.

Program Format: Two volumes of The Journal of Urology® are publishedannually. Each volume is comprised of 6 issues. Five clinically relevantarticles are selected by the editor to be offered for CME in each issue of TheJournal. For CME credit, the participant must be enrolled in the home studycourse for the year; complete the questionnaire on the opposite page andsubmit answers online at www.AUANet.org/CMEtests, answering 80% ofthe test questions correctly. Please complete the accompanying evaluation.The estimated time to complete each lesson is 2.0 hours. Each lesson is worthup to 2 AMA PRA Category 1 Credits™.

Program Enrollment: The cost to enroll in The Journal of Urology® HomeStudy Course 2010 Volumes 183/184 is only $60 for the full year. There are3 convenient ways to enroll:

● by MAIL: send completed form below including check or credit card infor-mation to address given below

● by FAX: send completed form below with credit card information to 410-

689-3937

● ONLINE at www.AUANet.org/jucme10

0022-5347/10/1845-2220/0THE JOURNAL OF UROLOGY®

© 2010 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.

2220 www.jurology.com

This product is only available to subscribers of The Journal of Urology®.Upon receipt of payment, you will have access to the online posttests atwww.AUANet.org/cmetests. Online exams are also available for 2008 (vol.179/180) and 2009 (vol. 181/182).

AUA Disclosure Policy: As a provider accredited by the ACCME, the AUAmust insure balance, independence, objectivity and scientific rigor in all itsactivities.

All faculty participating in an educational activity provided by the AUA arerequired to disclose to the provider any relevant financial relationships withany commercial interest. The AUA must determine if the faculty’s relation-ships may influence the educational content with regard to exposition orconclusion and resolve any conflicts of interest prior to the commencement ofthe educational activity. The intent of this disclosure is not to prevent facultywith relevant financial relationships from serving as faculty, but rather toprovide members of the audience with information on which they can maketheir own judgments.

Unlabeled or Unapproved Use of Drugs or Devices: It is the policy of theAUA to require the disclosure of all references to unlabeled or unapproveduses or drugs or devices prior to the presentation of educational content. Theaudience is advised that this continuing medical education activity maycontain reference(s) to unlabeled or unapproved uses of drugs or devices.Please consult the prescribing information for full disclosure of approveduses.

Disclaimer: The opinions and recommendations expressed by faculty, au-thors, and other experts whose input is included in this program are theirown and do not necessarily represent the viewpoint of the AUA.

Evidence-Based Content: As a provider of continuing medical educationaccredited by the ACCME, it is the policy of the AUA to review and certifythat the content contained in this CME activity is valid, fair, balanced,scientifically rigorous, and free of commercial bias.

System Requirements for Online Test: Windows 98, 2000, XP and above orMac OS 9 and above. Internet access.

Release Date: issue month, 2010. Expiration Date: issue month, 2013.

AUA Privacy and Confidentiality Policy:

http://www.auanet.org/cme/onlineeduconf.cfm

Email cme@AUAnet.org or hstudy@AUAnet.org with any questions.

The Journal of Urology® Home Study Course Enrollment Form

e Yes! I’d like to enroll for 2010 Volumes 183/184 for only $60! AUA ID:

Name:

Address:

City: State: Zip/Postal Code:

e Check (in US dollars drawn on a U.S. bank) enclosed for $ payable to: AUA Education and Research, Inc.

e Credit Card payment: e Visa e MasterCard e AmEx e Discover

Card Number: Expiration (mm/yyyy):

Cardholder’s Name (please print) Cardholder’s Signature:

Please mail or fax enrollment form to: AUA Education and Research Inc.P.O. Box 791080Baltimore, MD 21279-1080Telephone: 1-866-746-4282, ext. 3747Fax: 1-410-689-3937

Vol. 184, 2220-2221, November 2010Printed in U.S.A.

DOI:10.1016/j.juro.2010.07.028

2221

CME QUESTIONS FOR NOVEMBER 2010 ISSUE OF THE JOURNAL OF UROLOGY®

1. LONG-TERM RESULTS OF A STAGED APPROACH: CONTINENT URINARY DIVERSION IN PREPARATIONFOR RENAL TRANSPLANTATION (vol. 184, pp. 2038–2042)

Patients with end stage renal disease and dysfunctional or absent lower urinary tract:

a) are best treated with kidney transplantation and creation of a continent intestinal reservoir in the same operativesession

b) should undergo urinary diversion in preparation for renal transplantation in a staged approachc) are never allowed to undergo renal transplantation after creation of a continent intestinal reservoir in case of

preexisting malignancyd) should be excluded from complex reconstructive surgery due to very high complication ratese) are best treated with kidney transplantation combined with ureterosigmoidostomy in 1 operative session

2. SMOKING CESSATION ASSISTANCE FOR PATIENTS WITH BLADDER CANCER: A NATIONAL SURVEY OFAMERICAN UROLOGISTS (vol. 184, pp. 1901–1906)

Urologists who are most likely to provide smoking cessation counseling to patients with bladder cancer who smoke:

a) have never smokedb) are malec) have been in practice less than 5 yearsd) have received formal education on smoking cessation counselinge) treat a high volume of patients with bladder cancer yearly

3. ADRENOCORTICOTROPIC HORMONE IS INVOLVED IN REGULATION OF ANDROGEN SYNTHESIS INMEN RECEIVING ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER (vol. 184, pp.1971–1976)

Serum adrenal androgen levels during androgen deprivation therapy using gonadotropin-releasing hormone ago-nists in men with prostate cancer are positively correlated with:

a) serum adrenocorticotropic hormone levelsb) serum luteinizing hormone levelsc) serum growth hormone levelsd) serum thyroid-stimulating hormone levelse) serum follicle-stimulating hormone levels

4. CHRONIC KIDNEY DISEASE EPIDEMIOLOGY COLLABORATION VERSUS MODIFICATION OF DIET INRENAL DISEASE EQUATIONS FOR RENAL FUNCTION EVALUATION IN PATIENTS UNDERGOING PAR-TIAL NEPHRECTOMY (vol. 184, pp. 1867–1871)

The Chronic Kidney Disease Epidemiology Collaboration equation provides a more accurate estimate of glomerularfiltration rate (GFR) compared to the Modification of Diet in Renal Disease equation in which situation?

a) severely reduced GFRb) normal or slightly reduced GFRc) any GFRd) female patientse) acute renal failure

5. COMPARING PROSTATE SPECIFIC ANTIGEN TRIGGERS FOR INTERVENTION IN MEN WITH STABLEPROSTATE CANCER ON ACTIVE SURVEILLANCE (vol. 184, pp. 1942–1946)

For a patient on active surveillance, which prostate specific antigen (PSA) kinetic measure is most likely to triggera treatment recommendation that is not necessary?

a) PSA doubling time using the first and last PSA valuesb) PSA doubling time using all the PSA valuesc) PSA velocity using all the PSA values (overall PSA velocity)d) PSA velocity using the latest and previous PSA (successive PSA velocity)e) PSA velocity using latest PSA and that from 1 year ago (1-year PSA velocity)

Publication date: November 2010

Expiration date: November 2013